Our faculty will now address the most commonly asked questions.

Hi, my name is James Galvin, and I'm a professor of neurology at the University of Miami Miller School of Medicine in Boca Raton, Florida.

In this activity, we'll explore the use of anti-amyloid therapies to treat patients with early Alzheimer's disease, with a focus on long-term evidence.

In this first session, I'll discuss some of the latest advances in dosing and administration and review long-term efficacy clinical data.

Now, here we can see there are two approved therapies, the anti-amyloid immunotherapies for early-stage Alzheimer's disease.

These are monoclonal antibodies, and they've been approved by the FDA for the treatment of Alzheimer's disease.

They're indicated for patients with mild cognitive impairment or mild dementia stage of the disease.

Can you get a blood test to diagnose this? And I know this is a lot for you to respond to, but can you use a PET scan or a blood test? And what are new technologies that are developing or developed to recognize the differences?

So for Lewy body dementia, there is no blood test.

There is no imaging study at the present time.

There are candidate PET tracers that are being tested, but they're not available yet.

There is no blood test at the present time.

So there are two diagnostic tests that are currently available in the United States for trying to identify Lewy body dementia.

One is through spinal fluid.

Is this an indication of Louis body? Do you have suggestions about how to handle the accusations that I'm having affairs, locking him up or doing other mean things?